Home > Analytics > SUPRIYA LIFESCIENCE

SUPRIYA LIFESCIENCE
Intrinsic Value | Fundamental Analysis

BOM : 543434     NSE : SUPRIYA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
Feb 06,2023
Price(EOD): ₹ 200.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,614.83 Cr
Value of ₹ 1 Lac invested in SUPRIYA LIFESCIENCE
on Dec 28,2021 (price: ₹ 390.35)

₹ 1 L

₹ 0.51 L

1W : -6.7% 1M : -15.8% 1Y : -58.8%
COMMUNITY POLL
for SUPRIYA LIFESCIENCE
Please provide your vote to see the results
SUPRIYA LIFESCIENCE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
SUPRIYA LIFESCIENCE -6.7% -15.8% -58.8%
SUN PHARMACEUTICAL INDUSTRIES -1.1% 0.8% 15.6%
DIVIS LABORATORIES -16.3% -19.7% -31.6%
CIPLA 1.3% -5.4% 7.5%
DR REDDYS LABORATORIES 0.6% 1.3% -1.3%
TORRENT PHARMACEUTICALS 1.2% -1.3% 12%
ABBOTT INDIA 0.2% -5.5% 28.7%
ZYDUS LIFESCIENCES 9.2% 8.7% 4.7%
ALKEM LABORATORIES 2% 0.9% -14%

FUNDAMENTAL ANALYSIS OF SUPRIYA LIFESCIENCE

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 SUPRIYA is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF SUPRIYA LIFESCIENCE

 
Valuation Score
[As on : Feb 06,2023 ]

Ratio Standalone
P/E
P/B
P/S
12.62
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 127.96 Cr
[Latest Qtr - Sep2022 - Standalone Results ]

2.62
P/B Calculated based on Book Value of Rs 615.69 Cr
[Latest Year - Mar2022 - Standalone Results ]

3.15
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 29% undervalued companies ! Discover More →

FAIR VALUE OF SUPRIYA LIFESCIENCE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
61%
192%
-64%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF SUPRIYA LIFESCIENCE



SUPRIYA LIFESCIENCE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF SUPRIYA LIFESCIENCE

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.03
0.26
0.55
0.28
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF SUPRIYA LIFESCIENCE

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF SUPRIYA LIFESCIENCE

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
10.67%
64.96%
-9.02%
-33.22%
-24.14%
-45.04%
-64.74%
-71.04%
QtrlyTrend
-4
Latest Qtr: Sep2022
Quarterly Result Analysis →


SUPRIYA LIFESCIENCE related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 1.5% -3.4% -5.1%
S&P BSE MIDSMALLCAP 1.5% -3% -3.2%
S&P BSE ALLCAP 0.5% -3.1% -1.2%
S&P BSE HEALTHCARE -1.6% -3.6% -9.4%
No NSE index found

You may also like the below Video Courses


FAQ about SUPRIYA LIFESCIENCE


Is SUPRIYA LIFESCIENCE good for long term investment?

As on Feb 06,2023, the Fundamentals of SUPRIYA LIFESCIENCE look Strong and hence it may be good for long term investment! See Financial Performance of SUPRIYA LIFESCIENCE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SUPRIYA LIFESCIENCE UnderValued or OverValued?

As on Feb 06,2023, SUPRIYA LIFESCIENCE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SUPRIYA LIFESCIENCE ?

As on Feb 06,2023, the Intrinsic Value of SUPRIYA LIFESCIENCE is Rs. 124.37 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 124.37
Fair Value [Median EV / Sales Model] : Rs. 68.68
Fair Value [Median Price / Sales Model] : Rs. 556.19
Estimated Median Fair Value of SUPRIYA LIFESCIENCE : Rs. 124.37

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is SUPRIYA LIFESCIENCE trading at a Premium or Discount?

As on Feb 06,2023, SUPRIYA LIFESCIENCE is trading at a Premium of 61% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].